According to the report “North America Peripheral Vascular Devices Market,” published by Market Data Forecast, the North America market is projected to reach USD 4284.61 million by 2021, at a CAGR of 7.10% from 2015 to 2020.
The diminishing incidences of coronary angioplasties and the expanding intervention techniques have affected the surgical equipment market mainly in North America. The risk of restenosis in angioplasty procedures energizes the selection of novel advancements to limit post-surgical complications. Among different surgical devices, bio absorbable stents were observed to be a major breakthrough in the market. The bio absorbable stents market is relied upon to witness a huge CAGR of 62.2% during the forecast period. The achievement accomplished during the progressing studies is additionally expected to spur the market adoption.
Better diagnosis of vascular health when compared with conventional guiding catheters is reason behind the critical market development. In the market, retrievable inferior vena cava filter (IVC) possesses a remarkable market space as it turns into the best quality level for the treatment of DVT/PE in North America.
Get a comprehensive overview of the North America Peripheral Vascular Devices Market: http://www.marketdataforecast.com/market-reports/north-america-peripheral-vascular-device-market-2100/
North America Peripheral Vascular Devices Market: Drivers & Restraints
Growth in the value of the U.S. market for peripheral vascular devices is being driven by the aging U.S. population, improving public awareness of peripheral arterial disease (PAD) and improvements in medical device technology. The transcatheter embolization device market is expected to be the fastest growing segment, increasing at a CAGR in the mid-to-high teens over the forecast period. The strong growth in this market will be a result of the increase in usage of radiolabeled and drug-eluting beads as well as the increasing penetration rate of…